Leverkusen, September 1, 2022 – Cologne Local Court (Amtsgericht Köln) has appointed Kimberly Mathisen (50) to the Supervisory Board of Bayer AG. Mathisen, who holds dual U.S. and Norwegian citizenship, succeeds Professor Fei-Fei Li (45), who stepped down from the Board at the end of August due to personal medical reasons. Li, a leading expert in artificial intelligence and Professor of Computer Science at Stanford University in California, had been a member of the Supervisory Board since the 2021 Annual Stockholders’ Meeting. “We are delighted that we will be joined by Kimberly Mathisen. She is an outstanding personality who has more than 20 years of international experience in digitalization, technology, branded consumer goods and the pharmaceuticals business,” explained Professor Norbert Winkeljohann, Chairman of the Supervisory Board of Bayer AG. “At the same time, we very much regret the loss of Fei-Fei Li after such a short time. We will remain in contact with her and wish her all the very best for the future.”
Mathisen studied industrial engineering at the University of Illinois, United States, and graduated with a bachelor’s degree in 1994. She then worked for Procter & Gamble in the United States and in 2001 obtained an MBA from Harvard Business School. Also in 2001, she joined the pharmaceutical company Eli Lilly and held a variety of positions with growing responsibility in the United Kingdom, Norway and Germany. In 2013, she was appointed CEO of the Home & Personal Care Division of the Norwegian branded consumer goods company Orkla. In 2016, Mathisen joined Microsoft Corporation as General Manager with responsibility for the company’s entire business in Norway. Since 2021, she has been CEO of HUB Ocean, an independent non-profit foundation that is a joint initiative of the Aker Group and the World Economic Forum with a global ocean mandate. HUB Ocean is developing a groundbreaking data platform and applications and tools to pilot new approaches to ocean management. In addition, Mathisen has been a non-executive member of the Board of Directors of Aker Biomarine ASA in Norway since 2022. Kimberly Mathisen lives in Oslo, Norway.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.
Follow us on Twitter https://twitter.com/bayer
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.